CN Patent

CN101522173A — 钙受体活性化合物的固体复合物

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2009-09-02 · 17y expired

What this patent protects

本发明包括钙受体活性化合物固体复合物，制备该固体复合物的方法，包含该固体复合物的速释和控释药物制剂，以及以其治疗的方法。

USPTO Abstract

本发明包括钙受体活性化合物固体复合物，制备该固体复合物的方法，包含该固体复合物的速释和控释药物制剂，以及以其治疗的方法。

Drugs covered by this patent

cinacalcet-hydrochloride (CINACALCET HYDROCHLORIDE)

Patent Metadata

Patent number: CN101522173A
Jurisdiction: CN
Classification: —
Expires: 2009-09-02
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.